JPRN-jRCTs031180419招募中未知
Safety and efficacy of Aromatase inhibitor for fertility treatment of young breast cancer patients. - Effect of aromatase inhibitor for fertility treatment
Suzuki Nao0 个研究点目标入组 300 人开始时间: 2019年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 45age old（—）
- 性别
- Female
入选标准
- •1, Diagnosed as Breast cancer with cytological or histological study
- •2, There is consult by letter from medical doctor who follow up the patient
- •3, Age 18 to 45 years-old
- •4, Expectable long-survival case
- •5, Written informed consent
排除标准
- •1, After bilateral ovariectomy
- •2, The patients have past-history of ovarian cancer or cervical cancer(adenocarcinoma). If there are possibilities to get worse do to fertility treatment.
- •3, Pregnant women
- •4, During lactation
- •5, There are severe complications (e.g. uncontrollable DM, Auto immune disease which cause thrombosis easily, past history of thrombosis)
- •6, AST or ALT > 100U
- •7, BUN > 25mg/dl, or Cre > 2.0 mg/dl
- •8, The patients who are determined as ineligible cases
研究者
相似试验
已完成
1 期
Comparing the effect of Aromatase inhibitor (Letrozol) + Cabergoline (Dostinex) and letrozol alone on uterine myoma regressioIRCT201506205283N12Vice chancellor for Research,Tabriz University Of Medical Sciences76
招募中
2 期
Investigation of the effect of letrozole in the treatment of ectopic pregnancies compared to methotrexate.IRCT20170828035961N2Esfahan University of Medical Sciences40
招募中
3 期
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancerepithelial ovarian cancer2024-511219-78-00Swiss GO Trial Group300
进行中（未招募）
1 期
MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancerPatients with low and high grade serous and endometrioid ovarian cancer patients.EUCTR2019-002264-27-ATSwiss GO Trial Group540
招募中
3 期
Effect of Aromatase inhibitors combination with oral contraceptive pills versus GnRH agonist on uterine myomaterine Myoma.Leiomyoma of uterusIRCT20140820018866N7Tehran University of Medical Sciences42